See more : Shanghai ZJ Bio-Tech Co., Ltd. (688317.SS) Income Statement Analysis – Financial Results
Complete financial analysis of CareCloud, Inc. (CCLDO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CareCloud, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Artemis Strategic Investment Corporation (ARTEW) Income Statement Analysis – Financial Results
- Coffee Day Enterprises Limited (COFFEEDAY.NS) Income Statement Analysis – Financial Results
- Terreno Realty Corporation (TRNO) Income Statement Analysis – Financial Results
- Salvatore Ferragamo S.p.A. (SFER.MI) Income Statement Analysis – Financial Results
- Zwahlen & Mayr SA (ZWM.SW) Income Statement Analysis – Financial Results
CareCloud, Inc. (CCLDO)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.carecloud.com
About CareCloud, Inc.
CareCloud, Inc., a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's Software-as-a-Service platform includes revenue cycle management, practice management, electronic health record, business intelligence, telehealth, and patient experience management solutions, as well as complementary software tools and business services for medical groups and health systems. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinicians that render bills for their services. The company was formerly known as MTBC, Inc. and changed its name to CareCloud, Inc. in March 2021. CareCloud, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 117.06M | 138.83M | 139.60M | 105.12M | 64.44M | 50.55M | 31.81M | 24.49M | 23.08M | 18.30M | 10.47M | 10.02M | 10.09M |
Cost of Revenue | 70.82M | 84.43M | 86.92M | 64.82M | 41.19M | 31.25M | 17.68M | 13.42M | 11.63M | 10.64M | 4.27M | 4.26M | 4.51M |
Gross Profit | 46.24M | 54.39M | 52.68M | 40.30M | 23.25M | 19.29M | 14.13M | 11.08M | 11.45M | 7.67M | 6.20M | 5.76M | 5.58M |
Gross Profit Ratio | 39.50% | 39.18% | 37.74% | 38.34% | 36.08% | 38.17% | 44.42% | 45.22% | 49.61% | 41.89% | 59.20% | 57.50% | 55.33% |
Research & Development | 4.74M | 4.40M | 4.41M | 9.31M | 870.78K | 1.03M | 1.08M | 902.19K | 659.18K | 531.68K | 386.11K | 396.43K | 410.13K |
General & Administrative | 21.46M | 23.82M | 24.27M | 22.81M | 17.91M | 16.26M | 11.74M | 12.46M | 11.97M | 9.94M | 4.74M | 4.40M | 3.83M |
Selling & Marketing | 9.65M | 9.79M | 8.79M | 6.58M | 1.52M | 1.61M | 1.11M | 1.22M | 467.45K | 253.28K | 248.98K | 266.41K | 197.59K |
SG&A | 31.11M | 33.61M | 33.06M | 29.39M | 19.43M | 17.88M | 12.84M | 13.68M | 12.44M | 10.20M | 4.99M | 4.66M | 4.03M |
Other Expenses | 57.51M | 11.73M | 12.20M | 9.91M | 3.01M | 59.53K | 83.57K | -53.28K | 26.95K | -134.72K | 30.23K | 15.12K | 46.53K |
Operating Expenses | 93.36M | 49.73M | 49.66M | 48.61M | 23.31M | 21.76M | 18.23M | 19.69M | 17.69M | 13.52M | 6.33M | 5.74M | 4.99M |
Cost & Expenses | 164.17M | 134.17M | 136.58M | 113.43M | 64.50M | 53.01M | 35.91M | 33.11M | 29.32M | 24.16M | 10.60M | 10.00M | 9.49M |
Interest Income | 154.00K | 41.00K | 15.00K | 42.00K | 262.00K | 100.79K | 16.94K | 36.41K | 26.80K | 26.61K | 23.93K | 23.38K | 47.70K |
Interest Expense | 1.19M | 405.00K | 455.00K | 488.00K | 382.67K | 351.17K | 1.32M | 682.08K | 288.41K | 183.47K | 160.07K | 97.03K | 63.61K |
Depreciation & Amortization | 16.55M | 15.01M | 15.77M | 12.79M | 4.89M | 2.85M | 4.30M | 5.11M | 4.60M | 2.79M | 948.53K | 678.73K | 545.57K |
EBITDA | -31.29M | 21.03M | 19.22M | 4.57M | 3.13M | 909.13K | 126.81K | -2.81M | 337.42K | -1.36M | 1.10M | 892.75K | 1.32M |
EBITDA Ratio | -26.73% | 14.17% | 11.18% | 1.78% | 4.11% | 1.20% | 0.96% | -14.39% | -6.90% | -17.32% | 8.36% | 7.38% | 12.26% |
Operating Income | -47.12M | 4.06M | 3.53M | -8.26M | -421.10K | -2.54M | -4.52M | -7.90M | -4.46M | -4.04M | -127.52K | 22.02K | 597.06K |
Operating Income Ratio | -40.25% | 2.93% | 2.53% | -7.86% | -0.65% | -5.02% | -14.22% | -32.26% | -19.32% | -22.08% | -1.22% | 0.22% | 5.92% |
Total Other Income/Expenses | -1.92M | -1.00M | -536.00K | -439.00K | -746.02K | 243.95K | -975.19K | -698.95K | -91.33K | -291.58K | 94.01K | -31.30K | 116.67K |
Income Before Tax | -49.04M | 5.61M | 2.99M | -8.71M | -679.02K | -2.30M | -5.50M | -8.60M | -4.55M | -4.33M | -33.51K | 116.99K | 713.73K |
Income Before Tax Ratio | -41.89% | 4.04% | 2.14% | -8.29% | -1.05% | -4.54% | -17.28% | -35.11% | -19.71% | -23.67% | -0.32% | 1.17% | 7.07% |
Income Tax Expense | -364.00K | 177.00K | 157.00K | 103.00K | 192.78K | -157.39K | 67.81K | 196.80K | 137.79K | 176.53K | 144.49K | -4.00 | 243.84K |
Net Income | -48.67M | 5.43M | 2.84M | -8.81M | -871.80K | -2.14M | -5.57M | -8.80M | -4.69M | -4.51M | -178.00K | 117.00K | 469.90K |
Net Income Ratio | -41.58% | 3.91% | 2.03% | -8.38% | -1.35% | -4.23% | -17.49% | -35.91% | -20.31% | -24.64% | -1.70% | 1.17% | 4.66% |
EPS | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
EPS Diluted | -4.11 | 0.36 | 0.20 | -0.70 | -0.07 | -0.18 | -0.51 | -0.88 | -0.48 | -0.64 | -0.02 | 0.01 | 0.04 |
Weighted Avg Shares Out | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
Weighted Avg Shares Out (Dil) | 15.67M | 15.11M | 14.54M | 12.68M | 12.09M | 11.72M | 11.01M | 10.04M | 9.73M | 7.08M | 10.98M | 10.98M | 10.98M |
CareCloud's Managed Practice Pediatric Associates of Dayton Joins Dayton Children's Network
CareCloud Elevates Pathology Practice siParadigm with Cutting-Edge CareCloud Central Platform
CareCloud Takes Center Stage at The Arab Health Exhibition and Congress 2024
CareCloud Announces Suspension of its Dividends on Non-Convertible Series A and Series B Cumulative Redeemable Perpetual Preferred Stock
CareCloud Launches Redesigned and Enhanced Comprehensive Solution for Rehabilitation and Therapy Practices
CareCloud Welcomes Justin Pierce as Chief Sales Officer
Broadway Foot & Ankle Clinic Adds CareCloud Concierge for Tech-Enabled RCM
Ultrasound Express Selects CareCloud's talkEHR for Streamlined Patient Care
CareCloud Declares Dividends on Non-Convertible Series A and Series B Cumulative Redeemable Perpetual Preferred Stock
CareCloud, Inc. (CCLD) Q3 2023 Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports